| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +45K | 22.5% | $5.64 | +$254K |
| Sells | 5 | -155K | 77.5% | $7.97 | -$1.23M |
| Net | -4 | -110K | -54.9% | -$980K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Michelle Robertson | Evp, Chief Financial Officer | $1.16M | May 11, 2023 | ||
| Gilmore O'Neill | CEO, Director | $1.07M | -$805K | -42.8% | Sep 4, 2024 |
| Bruce Eaton | Evp, Cbo And Cto | $815K | -$8K | -0.97% | Dec 5, 2023 |
| Mark Shearman | Evp, Chief Scientific Officer | $714K | Feb 13, 2023 | ||
| Erick Lucera | Evp, Chief Financial Officer | $656K | -$125K | -16.1% | May 20, 2024 |
| Baisong Mei | Evp, Chief Medical Officer | $459K | -$230K | -33.4% | Sep 4, 2024 |
| Linda Burkly | Evp, Chief Scientific Officer | $396K | -$64.4K | -14% | Jul 25, 2024 |
| Jessica Hopfield | Director | $382K | +$254K | +198% | May 30, 2024 |
| Lisa Michaels | EVP/Chief Medical Officer | $247K | Dec 22, 2021 | ||
| Elliott Levy | Director | May 30, 2024 | |||
| Bernadette Connaughton | Director | May 30, 2024 | |||
| James C. Mullen | CEO, Director | Apr 14, 2022 | |||
| Andrew Hirsch | Director | May 30, 2024 | |||
| David Scadden | Director | May 30, 2024 | |||
| Emma Reeve | Director | May 30, 2024 | |||
| Meeta Chatterjee | Director | May 30, 2024 | |||
| Akshay Vaishnaw | Director | May 30, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|